Chief Scientific Officer Sequel Medtech Manchester, New Hampshire, United States
It is well known that the use of different correction targets impacts the time in range (TIR, glucose between 70-180 mg/dl) achieved. This poster highlights the first report of the performance of the twiist AID System, examining the impact of using a correction range that targets less than 100mg/dl compared to a target above that range. The TIR for those with the lower correction range is greater than for those with the higher correction range.